Ambroxol is a metabolite of bromhexine with similar are an interesting option when formulating an oral sustained actions and uses 1 . It is chemically described as trans-4-[(2-release (SR) of a drug. The dosage release properties of Amino-3,5-dibromobenzyl)amino]-cyclohexanol. It is an matrix devices may be dependent upon the solubility of expectoration improver and a mucolytic agent used in the the drug in the polymer matrix or, in case of porous treatment of acute and chronic disorders characterized by matrices, the solubility in the sink solution within the the production of excess or thick mucous. It has been particle's pore network 5 . Hydroxypropylmethylcellulose successfully used for decades in the form of its (HPMC) is the dominant hydrophilic vehicle used for the hydrochloride as a secretion-releasing expectorant in a preparation of oral controlled drug delivery systems 6 variety of respiratory disorders 2 . Its short biological half Numerous studies have been reported in literature life (4 h) 3, 4 that calls for frequent daily dosing (2 to 3 investigating the HPMC matrices to control the release of a . times) and therapeutic use in chronic respiratory diseases necessitates its formulation into sustained release dosage form.
The development of sustained/controlled release formulations of ambroxol hydrochloride is therefore of therapeutic relevance and can be used to provide a consistent dosage through sustaining an appropriate level of the drug over time. The simplest and least expensive way to control the release of the drug is to disperse it within an inert polymeric matrix. And hydrophilic matrices *For correspondence E-mail: cdl_scbasak@sancharnet.in variety of drugs from matrices [7] [8] [9] [10] [11] .
The objective of the present study was to formulate ambroxol hydrochloride SR matrix tablets using HPMC K100 polymer and to elucidate the release kinetics of ambroxol hydrochloride from HPMC matrices. We attempted a systematic approach to develop twice-daily sustained release ambroxol hydrochloride matrix tablets. www.ijpsonline.com
MATERIALS AND METHODS
Mumbai. Microcrystalline cellulose (MCC) and Aerosil R 200 were purchased from Coveral and Company, Chennai. Materials and excipients used in preparing tablets were IP grades. All other ingredients used throughout the study were of analytical grade and were used as received.
Calculation of theoretical release profile of ambroxol hydrochloride from SR tablets:
The total dose of ambroxol hydrochloride for twice-daily SR formulation was calculated by Robinson Eriksen magnesium stearate and compressed into tablets on a 16 station single rotary Cadmach machine using 12/32 DC punch.
Evaluation of tablets:
The prepared matrix tablets were evaluated for hardness, weight variation, thickness, friability and drug content.
Hardness of the tablets was tested using a Strong-Cobb hardness tester (Tab-machine, Mumbai). Friability of the tablets was determined in a Roche friabilator (Campbell Electronics, Mumbai). The thickness of the tablets was using available pharmacokinetic data 3, 4 . The measured by vernier callipers. Weight variation test was zero-order drug release rate constant (k o ) was calculated performed according to official method 13 . Drug content using equation k o = DI × k e , where DI is the initial dose for ambroxol hydrochloride was carried out by measuring (i.e., conventional dose = 30 mg) and k e is first-order rate the absorbance of samples at 248 nm using Shimadzu 1201 constant for overall elimination and was found to be 5.19 UV/Vis spectrophotometer and comparing the content mg/h. The loading dose was calculated as 19.42 mg.
from a calibration curve prepared with standard ambroxol Hence an oral controlled release formulation of ambroxol hydrochloride in the same medium. hydrochloride should contain a total dose of 76.51 mg ( ≅ 75 mg) and should release 19.42 mg in first 1 h like In vitro drug release studies: conventional tablets, and 5.19 mg/h up to 12 h thereafter.
The in vitro dissolution studies were carried out using USP 24 dissolution apparatus type II 14 (paddle method) at Preparation of matrix tablets: 100 rpm. Dissolution test was carried out for a total period Matrix tablets, each containing 75 mg ambroxol of 12 h using 0.1N HCl (pH 1.2) solution (750 ml) as hydrochloride, were prepared by direct compression dissolution medium at 37 ± 0.5° for first 2 h, and pH 6.8 technique. The drug polymer ratio was developed to phosphate buffer solution (1000 ml) for the rest of the adjust drug release as per theoretical release profile period. Ten millilitres of the sample was withdrawn at (Table 1) and to keep total weight of tablet constant for regular intervals and replaced with the same volume pre all the fabricated batches under experimental conditions warmed (37 ± 0.5°) fresh dissolution medium. The samples of preparations. The total weight of the matrix tablets was withdrawn were filtered through 0.45 µ membrane filter, 245 mg with different drug polymer (HPMC) ratios. A and drug content in each sample was analyzed after batch of 1000 tablets was prepared in each formula. The suitable dilution by above-mentioned spectrophotometer at composition of tablets is shown in Table 1 . MCC was 248 nm. The actual content in samples was read from a incorporated as filler excipient to maintain tablet weight calibration curve prepared with standard ambroxol constant. This water-insoluble filler was incorporated also hydrochloride. to counterbalance the faster solubility of the drug in presence of hydrophilic polymer and to provide a stable Kinetic analysis of dissolution data:
monolithic matrix. The ingredients were passed through sieve no. 30 and thoroughly mixed in a polythene bag. The powder blend was then lubricated with aerosol and The commonly adopted model for understanding release behaviour of a drug from hydrophilic matrix is a simple exponential equation 15 . The in vitro drug release data were fitted in the exponential equation (known as Korsmeyer-Peppas equation) M t /M ∝ = Kt n , where M t corresponds to the amount of drug release in time t, M ∝ is the total amount of drug released after an infinite time, K is a constant related to the structural and geometric properties of the drug delivery system (tablet) and n is the release exponent related to the mechanism of the release. Table 2 shows an analysis of diffusional release mechanism obtained by various values of n 16 . The n values used for elucidation of the drug release mechanism from the tablets were determined from log www.ijpsonline.com cumulative percentage of drug released versus log time plots [i.e., log (M t /M ∝ × 100) versus log t].
Stability studies:
One selected fabricated tablet batch was strip packaged and kept at 45° with 75% RH. Samples were withdrawn at 0, 15, 30 and 45 d for evaluation of appearance, drug content and in vitro drug release.
RESULTS AND DISCUSSION
concluded that there is a direct relationship between tablet hardness and sustaining of the drug release.
The release of drug depends not only on the nature of matrix but also upon the drug polymer ratio. As the percentage of polymer increased, the kinetics of release decreased. This may be due to structural reorganization of hydrophilic HPMC polymer. Increase in concentration of HPMC may result in increase in the tortuosity or gel strength of the polymer. When HPMC polymer is exposed to aqueous medium, it undergoes rapid
The results of hardness and friability of the prepared hydration and chain relaxation to form viscose gelatinous matrix tablets ranged from 4.5 ± 0.02 to 7.0 ± 0.69 and 0.18 layer (gel layer). Failure to generate a uniform and to 0.33 respectively ( Table 3 ). The tablet formulations in coherent gel may cause rapid drug release formulated employing same drug polymer ratio of 1:0.98, formulation F-III with higher tablet hardness gave slower The mechanism of release of ambroxol from batches F is 3.1 h) and complete release of ambroxol over a I to F-III was quasi (Fickian) diffusion, while F-IV period of 12 h compared to F-II (t 50 is 2 h). Hence we showed behaviour of Fickian diffusion ( Table 4 ). As shown in Table 4 , the n values increased as the drug polymer ratio of the tablets increased. Formulation F-V coupling of diffusion and erosion mechanism (known as (Table 5) . It may be concluded from the present study that slow, controlled and complete release of ambroxol over a period of 12 h was obtained from matrix tablets (F-V) formulated employing drug polymer ratio of 1:1.47. It is also evident from the results that formulation F-V is a better system for twice-daily SR of ambroxol hydrochloride. Formulation F-I to F-IV exhibited diffusion to quasi diffusion mechanism of drug release, whereas the mechanism of drug release from F-V was anomalous. 
